Eagle Pharmaceuticals

Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) is a fully diversified pharmaceutical company working to advance safe and effective treatments for critical care and oncology patients, their care teams, and the overall health system. The company discovers, develops, and markets medicines, and describes a first-in-class new chemical entity (NCE) pipeline with product candidates across oncology and critical care. Its product portfolio includes BYFAVO (remimazolam) for injection. The company is headquartered in Woodcliff Lake, NJ.

A fully diversified pharmaceutical company working to advance safe and effective treatments for critical care and oncology patients.

• BYFAVO (remimazolam) for injection

  A benzodiazepine indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.

• 2021.01.28

  Reported2021.01.28

  SEEDS and Eagle Pharmaceuticals announce multi-year partnership[5]SEEDS与Eagle Pharmaceuticals宣布多年合作prnewswire.com

  SEEDS announced a multi-year partnership with Eagle Pharmaceuticals to provide educational funding for 12 high-achieving students over two years and support existing students in SEEDS' Scholars programs.

• Unconfirmed

  Reported2020.02.12

  FDA grants final approval for Pemfexy[6]FDA最终批准Pemfexymyhealthyclick.com

  The FDA approved Eagle Pharmaceuticals’ Pemfexy for advanced cases of non-small cell lung cancer. Eagle’s CEO said the company had received final approval.

Read more

1. 1Eagle Pharmaceuticals, Inc. | Success is Where We Start | (NASDAQ: EGRX)eagleus.com
2. 2Products | Eagle Pharmaceuticals Inc. (EGRX)eagleus.com
3. 3About Us | Eagle Pharmaceuticals Inc. (EGRX)eagleus.com
4. 4Eagle Pharmaceuticalswikidata.org
5. 5SEEDS与Eagle Pharmaceuticals宣布多年合作prnewswire.com
6. 6FDA最终批准Pemfexymyhealthyclick.com